An important thread from @PutrinoLab about why we should not be excluding PCR/Ab negative #LongCovid from analysis. So proud of @PutrinoLab for refusing to succumb to reviewers’ demand -which would have resulted in exclusion of data from underrepresented minorities. (1/)
I wish to highlight the importance of their study in this short thread and why I think it should be published ASAP. 84 people with long covid were examined for various symptoms in a retrospective cross-sectional observational study.(2/)
First, look at the demographic data of those with #LongCovid. Compared to acute severe COVID (in older adults, male>female), long haulers appear more skewed towards women of younger age. (3/)
Second, of the participants (92%) with antibody test, only 39% were positive at the time of testing. This suggests that long haulers may be inducing suboptimal/short-lived Ab responses compared to other convalescent people. Only 28% PCR+: likely missed test time window. (4/)
Now look at the lingering symptoms. In addition to those shared during acute illness, others include fatigue, dizziness, irregular heart beat & temperature, numbness, heart palpitations, sleeping difficulty, hair loss, menstrual cycle issues…etc. Debilitating symptoms. (5/)
Importantly, symptoms are similar between those with confirmed (PCR+ or Ab+) and presumed (confirmed by a medical doctor) long COVID cases. These results support the inclusion of presumed long COVID patients who for one reason or another do not have a positive test. (6/)
As we move forward with scientific and clinical investigation into post-acute COVID-19 syndrome (PACS), this study provides important evidence for inclusion of presumed COVID cases and motivates the community to come to a consensus regarding inclusion criteria for PACS. (End)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
New study by @MHitchingsEpi et al shows that an inactivated vaccine CoronaVac is effective against COVID-19 in a setting of epidemic P.1 variant transmission in Brazil 🇧🇷. A thread. (1/n)
The authors conducted a matched test-negative case-control study to estimate the effectiveness of an
inactivated vaccine, CoronaVac, in healthcare workers in Manaus, where P.1 accounted for ~75% of the circulating virus.(2/n)
Vaccination with at least one dose was associated with an adjusted vaccine effectiveness of 49.6% (95% CI, 11.3 - 71.4) against symptomatic SARSCoV-2 infection >14 days after receiving the first dose. (3/n)
To address this question, we first looked at other confirmed cases of COVID reinfection. The number of such cases is limited due to the requirement for viral genome sequences in both infections. (2/)
We noted that very little information is available regarding the immune responses that developed during the first infection that can explain why someone would get reinfected. (3/)
@gushamilton and team asked through observational study of COVID patients post discharge - 82% with long lasting symptoms (>8 months). Symptoms compared 1 month post vaccination to the unvaccinated.🧵 (1/)
When compared to matched unvaccinated participants (n=22), those who had receive a vaccine (n=44) had no worsening of symptoms. This is reassuring for people with long covid thinking about getting a vaccine. (2/)
In fact, a small overall improvement in Long Covid symptoms, with a decrease in worsening symptoms (5.6% vaccinated vs 14.2% unvaccinated) and increase in symptom resolution (23.2% vaccinated vs 15.4% unvaccinated)(p=0.035) was reported. This is encouraging 👍🏼 (3/)
This video shows that vaccines have helped some people with #longCOVID with their symptoms. While the numbers are still small in some groups, there are encouraging signs (also via @DanielGriffinMD).
I present my hypothesis on how vaccines might improve #LongCovid 🧵 (1/)
Back when I first learned about #longcovid in June 2020, I proposed 3 possible mechanisms. 1) Persisten viral reservoir 2) Viral fragments/remnants (RNA, protein) 'viral ghost’ driving inflammation 3) Autoimmune response induced by the infection (2/)
Since then, many studies have provided support for all of these. Viral reservoirs are found in tissues, viral RNA is found in non-respiratory tissues ⬆️ inflammation (@virusninja) 👇🏽, and diverse autoantibodies found in COVID patients (@Aaronmring). (3/)
How well do various vaccines reduce severe COVID disease & death? Awesome @YaleMed students, @dariusdariusdar, @ChaneyKalinich, @Larson_HaleighT & Caroline Valdez put together summary tables from vaccine trials. Remarkable ability of vaccines to ⬇️ severe/lethal COVID! 🧵(1/n)
The phase 3 Pfizer BioNTech two-shot mRNA vaccine trial data. All the tables here and below indicate the # COVID-related death in the vaccinated as the right-most column (which is ZERO). (2/n)
Top 10 most downloaded articles in 2020 includes our review in the @AnnualReviews Virology - “Seasonality of Respiratory Viral Infections” by @MiyuMoriyama et al! It’s free to download: arevie.ws/3aYt32Y
Here let’s highlight other relevant pieces on the same topic (1/n)
Just to recap, seasonal factors that drive respiratory tract viral infections are mainly these three;
1) ⬇️ Temperature 2) ⬇️ Humidity (esp. indoor) 3) ⬇️ Sunlight/Vitamin D
(2/n)
A twitter thread that demonstrates the importance of humidity on antiviral defense through mucociliary clearance measured by @Ericsongg. (3/n)